The multiple etiologic factors involved in acne make the use of various medications necessary to treat the condition. This study aimed to determine the efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris. In a multicentre, randomized controlled, triple-blinded study, a total of 105 acne patients, with a clinical diagnosis of moderate to severe acne,were randomizedly divided into three groups (35 per group), for treatment of acne. The first group was treated with standard treatment alone, the second group received mupirocin plus standard treatment and the third group received rifampin plus standard treatment.There were three study visits according to Global Acne Grading System (GAGS): at baseli...
Objective: Niacinamide is a newly-approved anti-acne drug with a potent anti-inflammatory ef-fect. I...
Background: Acne vulgaris is a chronic inflammatory disease of pilosebaceous units. This disease occ...
Contains fulltext : 193304.pdf (Publisher’s version ) (Open Access)BACKGROUND: Acn...
Background: Acne vulgaris is the most common skin disease that can lead to disfigurement and psychol...
Introduction: Acne vulgaris is the most common dermatological disorder in adolescence. Treatment is ...
Introduction: Acne vulgaris is a chronic inflammatory dermatosis caused by Propionibacterium acnes. ...
Background: Acne treatments are sometimes expensive, and mild acne patients need some simpler form o...
Acne vulgaris is a common deep inflammatory disease. Erythromycin and clindamycin topical solutions ...
<b><i>Background/Aims:</i></b> Antibiotic-induced drug resistance requires new approaches in topical...
Background: Acne vulgaris is a common skin disease seen primarily in adolescents and young adults. A...
Background: Acne vulgaris is a chronic inflammatory skin disease that involves pilosebaceous units. ...
ABSTRACT Purpose: Address practice gaps in the treatment of moderate to severe acne in the context ...
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its ef...
IntroductionAcne can compromise facial esthetics and become a mental burden, especially when it occu...
Background: Recent studies have shown that human beta-defensin-1 (hBD-1) and (human beta-defensin-2 ...
Objective: Niacinamide is a newly-approved anti-acne drug with a potent anti-inflammatory ef-fect. I...
Background: Acne vulgaris is a chronic inflammatory disease of pilosebaceous units. This disease occ...
Contains fulltext : 193304.pdf (Publisher’s version ) (Open Access)BACKGROUND: Acn...
Background: Acne vulgaris is the most common skin disease that can lead to disfigurement and psychol...
Introduction: Acne vulgaris is the most common dermatological disorder in adolescence. Treatment is ...
Introduction: Acne vulgaris is a chronic inflammatory dermatosis caused by Propionibacterium acnes. ...
Background: Acne treatments are sometimes expensive, and mild acne patients need some simpler form o...
Acne vulgaris is a common deep inflammatory disease. Erythromycin and clindamycin topical solutions ...
<b><i>Background/Aims:</i></b> Antibiotic-induced drug resistance requires new approaches in topical...
Background: Acne vulgaris is a common skin disease seen primarily in adolescents and young adults. A...
Background: Acne vulgaris is a chronic inflammatory skin disease that involves pilosebaceous units. ...
ABSTRACT Purpose: Address practice gaps in the treatment of moderate to severe acne in the context ...
Introduction: Oral azithromycin has been advocated by some in the treatment of acne. However, its ef...
IntroductionAcne can compromise facial esthetics and become a mental burden, especially when it occu...
Background: Recent studies have shown that human beta-defensin-1 (hBD-1) and (human beta-defensin-2 ...
Objective: Niacinamide is a newly-approved anti-acne drug with a potent anti-inflammatory ef-fect. I...
Background: Acne vulgaris is a chronic inflammatory disease of pilosebaceous units. This disease occ...
Contains fulltext : 193304.pdf (Publisher’s version ) (Open Access)BACKGROUND: Acn...